Evidence map›Paper›PMID 30991641›Full record

ReviewPolymers2019

Some Important Issues of the Commercial Production of 1-D Nano-PANI.

Ying Wu, Jixiao Wang, Bin Ou, Song Zhao, Zhi Wang

Abstract readReview
In one paragraph

Review in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Thermal Annealing Effects of VMaterials (Basel, Switzerland) · 2022
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying WuCERC, School of Chemical Engineering and Technology Tianjin University, Tianjin 300354, China. wuying19901213@163.com.
Jixiao WangCERC, School of Chemical Engineering and Technology Tianjin University, Tianjin 300354, China. jxwang@tju.edu.cn.
Bin OuCERC, School of Chemical Engineering and Technology Tianjin University, Tianjin 300354, China. binou@tju.edu.cn.
Song ZhaoCERC, School of Chemical Engineering and Technology Tianjin University, Tianjin 300354, China. zhaosong@tju.edu.cn.
Zhi WangCERC, School of Chemical Engineering and Technology Tianjin University, Tianjin 300354, China. wangzhi@tju.edu.cn.

Funding

he National Natural Science Foundation of China 20836006Research Funds Projects of Ocean No. 201405013-5State Key Laboratory of Chemical Engineering project of China in 2012 . (SKL-ChE-12T12)the National High Technology Research and Development Program of 2012AA03A611the National Science and Technology Pillar Program (2015BAB10B00)the Program of Introducing Talents of Discipline to Universities No. B06006
6 · The paper itself

Abstract

One-dimensional polyaniline nano-materials (1-D nano-PANI) have great promise applications in supercapacitors, sensors and actuators, electrochromic devices, anticorrosive coatings, and other nanometer devices. Consequently, commercial production of 1-D nano-PANI at large-scale needs to be quickly developed to ensure widespread usage of this material. Until now, approaches-including hard template methods, soft template methods, interfacial polymerization, rapid mixing polymerization, dilute polymerization, and electrochemical polymerization-have been reported to be used to preparation of this material. Herein, some important issues dealing with commercial production of 1-D nano-PANI are proposed based on the complexity of the synthetic process, its characters, and the aspects of waste production and treatment in particular. In addition, potential solutions to these important issues are also proposed.

Indexed as

commercial productionone-dimensional polyaniline nano-materialssynthesis methodswaste treatment

Identifiers

PMID30991641
PMCPMC6523887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.